Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ JetBlue Drops 5% as Rebounding Oil Prices Hit Airline Stocks; United and Delta Fall 4% (24/7 Wall St.) +++ JETBLUE Aktie -3,88%

PFIZER Aktie

 >PFIZER Aktienkurs 
26.195 EUR    -1.4%    (TradegateBSX)
Ask: 26.225 EUR / 4600 Stück
Bid: 26.205 EUR / 4600 Stück
Tagesumsatz: 81147 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
PFIZER Aktie über LYNX handeln
>PFIZER Performance
1 Woche: -3,0%
1 Monat: +5,4%
3 Monate: +15,3%
6 Monate: +21,2%
1 Jahr: +20,8%
laufendes Jahr: +24,9%
>PFIZER Aktie
Name:  PFIZER INC. DL-,05
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US7170811035 / 852009
Symbol/ Ticker:  PFE (Frankfurt) / PFE (NYSE)
Kürzel:  FRA:PFE, ETR:PFE, PFE:GR, NYSE:PFE
Index:  S&P500
Profil:  Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines for people worldwide. Its current portfolio spans oncology, vaccines, internal medicine, inflammation and immunology, rare di..
>Volltext..
Marktkapitalisierung:  150861.55 Mio. EUR
Unternehmenswert:  194112.99 Mio. EUR
Umsatz:  57357.02 Mio. EUR
EBITDA:  20744.99 Mio. EUR
Nettogewinn:  3634.79 Mio. EUR
Gewinn je Aktie:  0.64 EUR
Schulden:  56497.01 Mio. EUR
Liquide Mittel:  1644.31 Mio. EUR
Operativer Cashflow:  12777.66 Mio. EUR
Bargeldquote:  0.45
Umsatzwachstum:  4.97%
Gewinnwachstum:  -57.37%
Dividende je Aktie:  1.49 EUR
Dividendenrendite:  5.86%
Dividendenschätzung:  5.93%
Div. Historie:  06.11.26 - 0.38583902€
24.07.26 - 0.378013€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  PFIZER
Letzte Datenerhebung:  12.11.26
>PFIZER Kennzahlen
Aktien/ Unternehmen:
Aktien: 5699.85 Mio. St.
Frei handelbar: 99.91%
Rückkaufquote: -
Mitarbeiter: 75000
Umsatz/Mitarb.: 0.75 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 1.74%
Bewertung:
KGV: 42.69
KGV lG: 9.67
KUV: 2.64
KBV: 1.91
PEG-Ratio: -
EV/EBITDA: 9.36
Rentabilität:
Bruttomarge: 65.1%
Gewinnmarge: 6.34%
Operative Marge: 25.95%
Managementeffizenz:
Gesamtkaprendite: 1.95%
Eigenkaprendite: 4.44%
 >PFIZER Anleihen 
>PFIZER Peer Group
 
12.11.26 - 17:33
"Not Just Going To Be Oversight": Dems Line Up Probes Of Ex-Chief Of Staff Susie Wiles (ZeroHedge)
 
"Not Just Going To Be Oversight": Dems Line Up Probes Of Ex-Chief Of Staff Susie Wiles Authored by Aldgra Fredly via The Epoch Times,Rep. Robert Garcia (D-Calif.) said on Nov. 10 that former White House chief of staff Susie Wiles could face a congressional probe once Democrats take over Congress next year.Garcia was responding to a reporter's question about whether the House Oversight Committee would investigate allegations that Wiles lobbied for interest groups during her tenure as chief of staff.As we reported on Nov. 10, the accusations come from former Kennedy aide Calley Means, who told Joe Rogan that Wiles said "I need the sugar industry money," and pollster Mark Mitchell, who said Wiles warned him off criticizing Pfizer. A Wiles spokesperson called the accusations "outrageous, defamatory, and provably false," and Ballard Partners, her former lobbying firm, says it has never represented Pfizer."We've already been looking at Susie Wiles. With all of this new information that's come out...
12.11.26 - 16:48
Blackstone Is Paying Up to $1.5 Billion for Pfizer′s Answer to Wegovy (24/7 Wall St.)
 
Pfizer just convinced Wall Street's biggest private investor to shoulder its obesity bet, yet the payoff for shareholders may not come from the drug at all. The real story sits in who keeps the upside and what arrives first....
12.11.26 - 06:18
Pfizer, Blackstone Strike Up To $1.5 Bln Co-Funding Deal To Develop Obesity Drug Berobenatide (AFX)
 
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and Blackstone Life Sciences announced a strategic co-funding agreement under which Blackstone-managed funds will pay Pfizer up to $1.5 billion in devel......
12.11.26 - 05:15
Blackstone Inc. to Invest Up to USD1.5B in Pfizer, Inc. for Obesity Drug R&D (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
11.11.26 - 23:57
Blackstone to provide Pfizer up to $1.5B to advance monthly GLP-1 for weight loss (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.11.26 - 23:24
Blackstone Puts Up $1.5 Billion for Pfizer Obesity Drug Studies (Bloomberg)
 
Pfizer Inc. struck a deal with Blackstone Inc. to secure as much as $1.5 billion in funding to develop one of its experimental obesity drugs, giving the company additional capital as it races to compete in the booming weight-loss market....
11.11.26 - 23:18
ORIC Pharmaceuticals auf der Stifel Healthcare Conference: Zuversicht für Krebspipeline trotz Pfizer-Verzögerung (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
11.11.26 - 23:03
Pfizer secures up to $1.5 billion from Blackstone for obesity drug development (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
10.11.26 - 21:09
Susie Wiles ′Pay-For-Play′ Scandal Goes Nuclear With New Pfizer Accusations; White House Responds (ZeroHedge)
 
Susie Wiles 'Pay-For-Play' Scandal Goes Nuclear With New Pfizer Accusations; White House Responds Pollster Mark Mitchell, an adviser to Vice President JD Vance, says Susie Wiles, Trump's former chief of staff, warned him off criticizing Pfizer, which he called her old lobbying firm's "number one client."Before she ran Donald Trump's 2024 campaign and then his White House, Wiles spent nearly a decade as a managing partner at Ballard Partners, the Florida-founded lobbying firm that has become the top-earning shop in Washington under Trump. Since she left (or was booted) as CoS shortly after midterms, several people in Trump's administrative orbit have accused her of using the job to protect the industries paying her old firm at the expense of the President's health agenda.The loudest of them has been Calley Means, a former top aide to Health Secretary Robert F. Kennedy Jr., who, as we reported, told Joe Rogan that Wiles said "I need the sugar industry money." On Sunday...
10.11.26 - 12:30
Pfizer-Aktie nach dem Jahreshoch: Wie geht es jetzt weiter? (Sharedeals)
 
Die Aktie des US-Pharmakonzerns Pfizer gehört 2026 zu den überraschenden Gewinnern an den Börsen. Nach schwierigen Jahren hat das Unternehmen wieder an Dynamik gewonnen. Trotz der deutlichen Kurssteigerungen sehen Analysten und langfristig orientierte Anleger weiterhin Chancen. Neue Medikamente treiben das Wachstum Die jüngsten Quartalszahlen unterstreichen die positive Entwicklung. Zwar stagnierte der Konzernumsatz mit 16,58 Milliarden […] The post Pfizer-Aktie nach dem Jahreshoch: Wie geht es jetzt weiter? first appeared on sharedeals.de....
10.11.26 - 12:12
Pfizer Hits a New 52-Week High. Here′s Why It′s Not Too Late to Buy the Stock (Fool)
 
This surprising healthcare stock has been outperforming the markets this year....
09.11.26 - 15:48
Why Pfizer Believes It Can Be a Leader in the GLP-1 Market, Even Though Its Drug May Not Debut Until 2028 (Fool)
 
Investors shouldn't count out Pfizer in the GLP-1 market just yet....
09.11.26 - 14:48
Medicus Pharma sharpens focus on Pfizer-licensed cancer drug CD228V, trims costs in Q3 (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
08.11.26 - 15:09
Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focus (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.11.26 - 22:24
Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials (Fool)
 
Everyone is talking about the GLP-1 battle between Eli Lilly and Novo Nordisk, but Pfizer wants in on the fight, too....
07.11.26 - 01:36
Pfizer vs. AbbVie: Higher Yield and Cheaper Valuation Give One the Clear Edge (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.26 - 17:06
Moderna Climbs 5% as Surprise Profit and Raised Outlook Beat Forecasts; Pfizer Dips, BioNTech Edges Higher (24/7 Wall St.)
 
A quarter that produced a surprise profit and a bigger 2026 forecast is sending Moderna (NASDAQ:MRNA) higher again. Moderna stock is at $254.07 in morning trading, up 5%. The stock has climbed 762% year to date, driven largely by enthusiasm for the company's cancer vaccine work. Part of the stock's initial reaction to the report […]...
06.11.26 - 14:00
Buy, Sell, or Hold? Friday’s Top Upgrades and Downgrades: Becton Dickinson, BJ’s Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More (24/7 Wall St.)
 
  Pre-Market Stock Futures: Futures are mixed this Friday morning, with the Dow Jones trading lower, but Nasdaq futures are higher as AI stocks catch a bid after the big post-election rally turned into a massive post-election sell-off. Concerns over Artificial Intelligence and Data Center spending drove the selling, and stocks that were already overbought […]...
06.11.26 - 10:15
JD HEALTH To Ink Agreements With 20+ Global Pharma and Healthcare Brands at CIIE (AAStocks)
 
JD HEALTH (06618.HK) CEO Cao Dong said the group will sign agreements with more than 20 global pharmaceutical and healthcare brands at the 9th China International Import Expo (CIIE), including Pfizer, Inc. (PFE.US), Merck & Company, Inc. (MRK.US), Novo, and Centrum / Caltrate, covering pharmaceuticals, nutrition and healthca......
06.11.26 - 00:03
XETR: DIVIDEND/INTEREST INFORMATION - 06.11.2026 - US7170811035 (XETRA)
 
Das Instrument PFE US7170811035 PFIZER INC. DL-,05 EQUITY wird ex Dividende/Zinsen gehandelt am 06.11.2026 The instrument PFE US7170811035 PFIZER INC. DL-,05 EQUITY has its ex-dividend/interest day on 06.11.2026...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer gesund ist und arbeiten will, hat auf dieser Welt nichts zu fürchten. - Gotthold Ephraim Lessing
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!